Cargando…
Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic
Autores principales: | Zhou, Si-Yu, Shu, Wen-Jing, Pan, Hai-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130680/ https://www.ncbi.nlm.nih.gov/pubmed/35649743 http://dx.doi.org/10.1016/j.arcmed.2022.05.005 |
Ejemplares similares
-
Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic
por: NORIS-GARCÍA, ELENA, et al.
Publicado: (2022) -
Reply to “The SARS-COV Pandemic Does Not Absolve From Solid Medical Trade”
por: Okor, Ivana, et al.
Publicado: (2021) -
New-onset Evans syndrome in a patient with SLE post SARS-CoV2 mRNA vaccination
por: Ng, Timothy Y. M., et al.
Publicado: (2022) -
In Reply—Repeated Testing in SARS-CoV-2 Infection
por: Shah, Aditya, et al.
Publicado: (2020) -
Reply to “Intensification of an Essential Tremor by SARS-CoV-2”
por: Passaretti, Massimiliano, et al.
Publicado: (2022)